Ichnos Sciences signs licensing pact with Astria Therapeutics for OX40 antagonist monoclonal…
Astria Therapeutics is granted global rights to develop and commercialise OX40 portfolio, comprised of Telazorlimab and its…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.